Helen Torley

Affiliations

  • President And Ceo at Halozyme Therapeutics Inc. (HALO), 2025-06-24
  • Director at Quest Diagnostics Inc (DGX), 2021-05-25
  • Director at Relypsa Inc (RLYP), 2016-09-02
  • Evp, Chief Commercial Officer at Onyx Pharmaceuticals Inc (ONXX), 2013-10-04
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
HALO $8.92 50,000 $446,000.00 50,000 2014-09-16 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
HALO $53.91 15,511 $836,213.52 733,719 2025-06-24 Filing
HALO $53.11 4,489 $238,406.30 749,230 2025-06-24 Filing
HALO $52.57 20,000 $1,051,460.00 733,719 2025-06-23 Filing
HALO $52.96 20,000 $1,059,200.00 733,719 2025-06-20 Filing
HALO $53.91 2,404 $129,590.02 676,744 2024-10-09 Filing